Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

BACKGROUND: Hyperuricemia has recently been identified as a risk factor of cardiovascular diseases; however, prognostic value of hyperuricemia in patients with ST-segment elevation myocardial infarction (STEMI) remained unclear. Simultaneously, the mechanism of this possible relationship has not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xiao-Fang, He, Chen, Zhu, Pei, Zhang, Che, Song, Ying, Xu, Jing-Jing, Yao, Yi, Xu, Na, Jiang, Ping, Jiang, Lin, Gao, Zhan, Zhao, Xue-yan, Gao, Li-jian, Song, Lei, Yang, Yue-Jin, Gao, Run-Lin, Xu, Bo, Yuan, Jin-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160184/
https://www.ncbi.nlm.nih.gov/pubmed/35663308
http://dx.doi.org/10.3389/fendo.2022.852247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160184/
https://www.ncbi.nlm.nih.gov/pubmed/35663308
http://dx.doi.org/10.3389/fendo.2022.852247

Ejemplares similares